Modulated Electro-Hyperthermia Techniques in Oncology

Modulated electro-hyperthermia (mEHT) is an emerging adjunct to conventional cancer therapies that combines amplitude-modulated radiofrequency energy with controlled heating to exploit the distinct electrical and thermal properties of malignant tissue. By focussing a 13.56 MHz electromagnetic field via capacitive coupling, mEHT generates not only a mild hyperthermic environment (around 42 °C) but also non-thermal electromagnetic effects at the cell membrane. These combined actions induce selective tumour cell stress, promote apoptotic signalling pathways and enhance tumour perfusion and drug uptake. Preclinical studies have revealed mEHT-mediated DNA damage, activation of heat shock proteins and immunogenic cell death signals, laying the groundwork for systemic anti-tumour immune responses, including abscopal effects. Clinically, mEHT has been applied across a range of solid tumours, often in combination with chemotherapy or radiotherapy, showing improvements in local disease control, survival outcomes and quality of life. Its non-invasive delivery, ability to overcome hypoxic resistance and synergy with standard treatments underline its global significance as a versatile, precision-targeted hyperthermia technique in oncology.

Research from Nature Portfolio

Recent mechanistic investigations have elucidated the non-thermal contributions of radiofrequency hyperthermia to cancer cell inhibition. In a preclinical model using human colon cancer cell lines, water bath heating was contrasted with 13.56 MHz radiofrequency hyperthermia at identical temperatures. Radiofrequency treatment not only reduced proliferation and clonogenic survival more effectively than conventional heating but also generated additional ion fluxes across cell membranes. Computational modelling of the electromagnetic field interaction with membrane ion channels indicated that the rectified RF component could induce microvolt-level direct currents, sufficient to perturb ionic homeostasis. These insights provide a theoretical framework for understanding how mEHT’s electromagnetic component enhances tumour cell killing beyond mere temperature elevation and supports optimisation of treatment parameters for improved therapeutic index.

Modulated Electro-Hyperthermia Techniques in Oncology publication trend

The graph below shows the total number of articles in modulated electro-hyperthermia techniques in oncology across all publications each year (not limited to Nature Index journals).

Technical terms

Modulated electro-hyperthermia (mEHT): A targeted oncology technique combining amplitude-modulated radiofrequency energy with mild hyperthermia to selectively stress and kill tumour cells.

Non-thermal effects: Biological responses induced by electromagnetic fields that are independent of bulk temperature rise, often mediated via ion channel perturbation and membrane depolarisation.

Pulsed radiofrequency: Delivery of radiofrequency energy in intermittent high-intensity bursts to enhance tissue penetration, control energy deposition and minimise surface heating.

Abscopal effect: Systemic anti-tumour response and regression of distant, untreated lesions triggered by localized therapy, mediated by immune activation.

Hypoxia-inducible factor 1-alpha (HIF1-α): A transcription factor stabilised under low oxygen that drives angiogenesis and metabolic adaptation in tumours.

Capacitive coupling: A method of transferring electromagnetic energy through an alternating electric field between two electrodes, commonly used in mEHT applicators.

References

1. Pulsing Addition to Modulated Electro-Hyperthermia. Bioengineering (2024).
2. Digoxin-Mediated Inhibition of Potential Hypoxia-Related Angiogenic Repair in Modulated Electro-Hyperthermia (mEHT)-Treated Murine Triple-Negative Breast Cancer Model. ACS Pharmacology & Translational Science (2024).
3. The effect of modulated electro-hyperthermia on local disease control in HIV-positive and -negative cervical cancer women in South Africa: Early results from a phase III randomised controlled trial. PLOS ONE (2019).
4. The Clinical Validation of Modulated Electro-Hyperthermia (mEHT). Cancers (2023).
5. Review of the Clinical Evidences of Modulated Electro-Hyperthermia (mEHT) Method: An Update for the Practicing Oncologist. Frontiers in Oncology (2019).
6. Upregulation of heat shock proteins and the promotion of damage-associated molecular pattern signals in a colorectal cancer model by modulated electrohyperthermia. Cell Stress and Chaperones (2014).
7. Modulated Electro-Hyperthermia-Induced Tumor Damage Mechanisms Revealed in Cancer Models. International Journal of Molecular Sciences (2020).
8. Non-thermal membrane effects of electromagnetic fields and therapeutic applications in oncology. International Journal of Hyperthermia (2021).